The influence of perceived benefits on acceptance of GM applications for allergy prevention

Health, Risk and Society

Volumn 10, Issue 3, 2008, Pages 263-282

  Schenk, M F ^a   Fischer, A R H ^a   Frewer, L J ^a   Gilissen, L J W J ^a   Jacobsen, E ^a   Smulders, M J M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Allergy prevention; Genetic modification; GM societal acceptance

Indexed keywords

ALLERGEN;

ADULT; APPLE; ARTICLE; ATTITUDE TO HEALTH; BIRCH; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DNA MODIFICATION; FEMALE; FOOD ALLERGY; GRASS; HAY FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; PLANT; PRIMARY PREVENTION; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; RISK REDUCTION; SELF REPORT; WESTERN EUROPE;

EID: 49549102402     PISSN: 13698575     EISSN: 14698331     Source Type: Journal    
DOI: 10.1080/13698570802160947     Document Type: Article

References (44)

1. Aberg, N., Hesselmar, B., Aberg, B. and Eriksson, B. (1995) Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clinical and experimental allergy, 25, pp. 815-819.
2. Bhalla, P. L., Swoboda, I. and Singh, M. B. (1999) Antisense-mediated silencing of a gene encoding a major ryegrass pollen allergen. Proceedings of the national academy of science of the USA, 96, pp. 11676-11680.
3. Bohle, B., Radakovics, A., Jahn-Schmid, B., Hoffmann-Sommergruber, K., Fischer, G. F. and Ebner, C. (2003) Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: Evidence at the T cell level. European journal of immunology, 33, pp. 3303-3310.
4. Bolhaar, S. T. H. P., Van De Weg, W. E., Van Ree, R., Gonzalez-Macebo, E., Zuidmeer, L. Bruijnzeel-Koomen, C. A. F. M. et al. (2005) In vivo assessment with prick-to-prick testing and double-blind, placebo-controlled food challenge of allergenicity of apple cultivars. Journal of allergy and clinical immunology, 116, pp. 1080-1086.
5. Fagan, J. K., Scheff, P. A., Hryhorczuk, D., Ramakrishnan, V., Ross, M. and Persky, V. (2001) Prevalence of asthma and other allergic diseases in an adolescent population: Association with gender and race. Annals of allergy, asthma and immunology, 86, pp. 77-184.
6. Fernandez-Rivas, M. and Miles, S. (2004) Food allergies: Clinical and psychosocial perspectives. Plant food allergies, pp. 1-23. Blackwell, Oxford
7. Ferreira, F., Hawranek, T., Gruber, P., Wopfner, N. and Mari, A. (2004) Allergic cross-reactivity: From gene to the clinic. Allergy, 59, pp. 243-267.
8. Finucane, M. L., Slovic, P., Mertz, C. K., Flynn, J. and Satterfield, T. A. (2000) Gender, race, and perceived risk: The 'white male' effect. Health, risk & society, 2, pp. 159-172.
9. Frewer, L. (2000) Riskperception and risk communication about food safety issues. Nutrition bulletin, 25, pp. 31-33.
10. Frewer, L. (2003) Societal issues and public attitudes towards genetically modified foods. Trends, food science & technology, 14, pp. 319-332.
11. Frewer, L., Howard, C. and Shepherd, R. (1997) Public concerns in the United Kingdom and specific applications of genetic engineering: Risk, benefit, and ethics. Science, technology & human values, 22, pp. 98-124.
12. Fritsch, R., Bohle, B., Vollmann, U., Wiedermann, U., Jahn-Schmid, B. Krebitz, M. et al. (1998) Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells. Journal of allergy and clinical immunology, 102, pp. 679-686.
13. Gaskell, G., Allansdottir, A., Allum, N., Corchero, C., Fischler, C. Hampel, J. et al. (2006) Europeans and biotechnology in 2005: Patterns and trends, Eurobarometer 64.3
14. Gilissen, L. J. W. J., Bolhaar, S. T. H., Matos, C. I., Rouwendal, G. J. A., Boone, M. J. Krens, F. A. et al. (2005) Silencing the major apple allergen Mal d 1 by using the RNA interference approach. Journal of allergy and clinical immunology, 115, pp. 364-369.
15. Goodman, R. E., Hefle, S. L., Taylor, S. L. and Van Ree, R. (2005) Assessing genetically modified crops to minimize the risk of increased food allergy: A review. International archives of allergy and immunology, 137, pp. 153-166.
16. Gowland, M. H. (2001) Food allergen avoidance-the patient's viewpoint. Allergy, 56, pp. 117-120.
17. Herman, E. M., Helm, R. M., Jung, R. and Kinney, A. J. (2003) Genetic modification removes an immunodominant allergen from soybean. Plant physiology, 132, pp. 36-43.
18. Hourihane, J. O'B. (2001) The threshold concept in food safety and its applicability to food allergy. Allergy, 56, pp. S86-S90.
19. Juniper, E. F. and Guyatt, G. H. (1991) Development and testing of a new measure of health-status for clinical-trials in Rhinoconjunctivitis. Clinical and experimental allergy, 21, pp. 77-83.
20. Juniper, E. F., Thompson, A. K., Ferrie, P. J. and Roberts, J. N. (2000) Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire. Clinical and experimental allergy, 30, pp. 132-140.
21. Knibb, R. C., Armstrong, A., Booth, D. A., Platts, R. G., Booth, I. W. and Macdonald, A. (1999) Psychological characteristics of people with perceived food intolerance in a community sample. Journal of psychosomatic research, 47, pp. 545-554.
22. Lemmetyinen, J., Keikonen, K. and Sopanen, T. (2004) Prevention of the flowering of a tree, silver birch. Molecular breeding, 13, pp. 243-249.
23. Marklund, B., Ahlstedt, S. and Nordstrom, G. (2004) Health-related quality of life among adolescents with allergy-like conditions - with emphasis on food hypersensitivity. Health and quality of life outcomes, 2, p. 65.
24. Mccabe, M., Lyons, R. A., Hodgeson, P., Griffiths, G. and Jones, R. (2001) Management of peanut allergy. Lancet, 357, pp. 1531-1532.
25. Meltzer, E. O. (2001) Quality of life in adults and children with allergic rhinitis. Journal of allergy and clinical immunology, 108, pp. S45-S53.
26. Miles, S. and Frewer, L. J. (2001) Investigating specific concerns about different food hazards. Food quality and preference, 12, pp. 47-61.
27. Miles, S., Brennan, M., Kuznesof, S., Ness, M., Ritson, C. and Frewer, L. J. (2004) Public worry about specific food safety issues. British food journal, 106, pp. 9-22.
28. Miles, S., Fordham, R., Mills, C., Valovirta, E. and Mugford, M. (2005) A framework for measuring costs to society of IgE-mediated food allergy. Allergy, 60, pp. 996-1003.
29. Mills, E. N. C., Valovirta, E., Madsen, C., Taylor, S. L., Vieths, S. Anklam, E. et al. (2004) Information provision for allergic consumers-where are we going with food allergen labelling?. Allergy, 59, pp. 1262-1268.
30. Petrovska, N., Wu, X., Donato, R., Wang, Z., Ong, E. K. Jones, E. et al. (2005) Transgenic ryegrasses (Lolium spp.) with down-regulation of main pollen allergens. Molecular breeding, 14, pp. 489-501.
31. Pastorello, E. A., Pravettoni, V., Farioli, L., Ispano, M., Fortunato, D., Monza, M., Giuffrida, M. G., Rivolta, F., Scibola, E., Ansaloni, R., Incorvaia, C., Conti, A. and Ortolani, C. (1999) Clinical role of a lipid transfer protein that acts as a new apple - specific allergen. Journal of allergy and clinical immunology, 104, pp. 1099-1106.
32. Schouten, H. J., Krens, F. A. and Jacobsen, E. (2006) Do cisgenic plants warrant less stringent oversight?. Nature biotechnology, 24, p. 753.
33. Sicherer, S. H., Noone, S. A. and Munoz-Furlong, A. (2001) The impact of childhood food allergy on quality of life. Annals of allergy, asthma and immunology, 87, pp. 461-464.
34. Siegrist, M. (1998) Belief in gene technology: The influence of environmental attitudes and gender. Personality and individual differences, 24, pp. 861-866.
35. Siegrist, M. (2000) The influence of trust and perceptions of risks and benefits on the acceptance of gene technology. Risk analysis, 20, pp. 195-203.
36. Slovic, P. (1987) Perception of risk. Science, 236, pp. 280-285.
37. Strachan, D. P. (1989) Hay-fever, hygiene, and household size. British medical journal, 299, pp. 1259-1260.
38. Taylor, S. L. (2003) Safety assessment of foods produced through agricultural biotechnology. Nutrition reviews, 61, pp. S135-S140.
39. Titchener, G. D. and Sapp, S. G. (2002) A comparison of two approaches to understanding consumer opinions of biotechnology. Social behavior and personality, 30, pp. 373-381.
40. UCB Institute of Allergy (1997) European allergy white paper, UCB, Brussels
41. Van Putten, M. C., Frewer, L. J., Gilissen, L. J. W. J., Gremmen, B., Peijnenburg, A. A. C. M. and Wichers, H. J. (2006) Novel foods and food allergies: A review of the issues. Trends in food science and technology, 17, pp. 289-299.
42. Wensing, M., Akkerdaas, J. H., Van Leeuwen, A., Stapel, S. O., Bruijnzeel-Koomen, C. A. F. M. Aalberse, R. C. et al. (2002) IgE to Bet v 1 and profilin: Cross-reactivity patterns and clinical relevance. Journal of allergy and clinical immunology, 110, pp. 435-442.
43. Wuthrich, B., Schindler, C., Leuenberger, P., Ackermann-Liebrich, U., Alean, P. Blaser, K. et al. (1995) Prevalence of atopy and pollinosis in the adult-population of Switzerland (SAPALDIA study). International archives of allergy and immunology, 106, pp. 149-156.
44. Zechendorf, B. (1994) What the public thinks about biotechnology. Better than synthetic food but worse than organ-transplantation. A survey of opinion polls. Biotechnology, 12, pp. 870-875.